GSK Investigational Site

Truro, Cornwall TR1 3LJ

0 studies enrolling now · 3 studies all time

What they study most

Arthritis, Rheumatoid, Multiple Myeloma, Thrombocytopaenia

Studies at this site

• To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) — Completed
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy — Completed
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed